
Vijay Sankaran
Articles
-
Oct 23, 2024 |
nature.com | Vijay Sankaran
An emerging treatment option for genetic diseases that affect the blood and immune system is haematopoietic stem cell (HSC) gene therapy. In ‘autologous’ HSC gene therapy, a person’s own haematopoietic stem and progenitor cells (HSPCs) are collected and genetically modified to restore normal gene function, and then transplanted back into that person to re-establish the production of blood and immune cells (haematopoiesis) in the bone marrow.
-
Aug 24, 2024 |
biorxiv.org | Chen Weng |Jonathan S. Weissman |Vijay Sankaran
AbstractThe detection of mitochondrial DNA (mtDNA) mutations in single cells holds considerable potential to define clonal relationships coupled with information on cell state in humans. Previous methods focused on higher heteroplasmy mutations that are limited in number and can be influenced by functional selection, introducing biases for lineage tracing.
-
Jun 12, 2024 |
nature.com | Aoxing Liu |Giulio Genovese |Yajie Zhao |Matti Pirinen |Xiaoxi Liu |Bryan R. Gorman | +15 more
AbstractMosaic loss of the X chromosome (mLOX) is the most common clonal somatic alteration in leukocytes of female individuals1,2, but little is known about its genetic determinants or phenotypic consequences. Here, to address this, we used data from 883,574 female participants across 8 biobanks; 12% of participants exhibited detectable mLOX in approximately 2% of leukocytes. Female participants with mLOX had an increased risk of myeloid and lymphoid leukaemias.
-
Feb 29, 2024 |
nature.com | Enyong Dai |Xin McRae Chen |Xuejun Jiang |Rui Kang |Valerian E. Kagan |Ana J. García-Sáez | +27 more
AbstractFerroptosis, an intricately regulated form of cell death characterized by uncontrolled lipid peroxidation, has garnered substantial interest since this term was first coined in 2012. Recent years have witnessed remarkable progress in elucidating the detailed molecular mechanisms that govern ferroptosis induction and defence, with particular emphasis on the roles of heterogeneity and plasticity.
-
Nov 4, 2023 |
ciotalknetwork.com | Vijay Sankaran
As AI gets more complex, making decisions harder to understand, Explainable AI (XAI) becomes crucial. It’s not just about tech anymore; it’s about trust, ethics, and clear communication. So, a big challenge emerges: How are business and IT heads working together to balance a clear AI “story” with a highly accurate model? And with different AI rules in different countries, how are they keeping up and making the right calls in this fast-evolving AI world?
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →